nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Abdominal bloating—Progesterone—uterine cancer	0.0448	0.0448	CcSEcCtD
Betahistine—Abdominal bloating—Medroxyprogesterone Acetate—uterine cancer	0.0406	0.0406	CcSEcCtD
Betahistine—Digestion impaired—Progesterone—uterine cancer	0.0319	0.0319	CcSEcCtD
Betahistine—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.0289	0.0289	CcSEcCtD
Betahistine—Abdominal distension—Progesterone—uterine cancer	0.0135	0.0135	CcSEcCtD
Betahistine—Asthma—Progesterone—uterine cancer	0.0134	0.0134	CcSEcCtD
Betahistine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0128	0.0128	CcSEcCtD
Betahistine—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Betahistine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.0121	0.0121	CcSEcCtD
Betahistine—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0119	CcSEcCtD
Betahistine—Erythema multiforme—Progesterone—uterine cancer	0.0101	0.0101	CcSEcCtD
Betahistine—Immune system disorder—Progesterone—uterine cancer	0.00967	0.00967	CcSEcCtD
Betahistine—Flatulence—Progesterone—uterine cancer	0.00919	0.00919	CcSEcCtD
Betahistine—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00918	0.00918	CcSEcCtD
Betahistine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00877	0.00877	CcSEcCtD
Betahistine—Ill-defined disorder—Progesterone—uterine cancer	0.00865	0.00865	CcSEcCtD
Betahistine—Angioedema—Progesterone—uterine cancer	0.00852	0.00852	CcSEcCtD
Betahistine—Malaise—Progesterone—uterine cancer	0.00841	0.00841	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00836	0.00836	CcSEcCtD
Betahistine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00832	0.00832	CcSEcCtD
Betahistine—Dermatitis atopic—Epirubicin—uterine cancer	0.00826	0.00826	CcSEcCtD
Betahistine—Convulsion—Progesterone—uterine cancer	0.00808	0.00808	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00788	0.00788	CcSEcCtD
Betahistine—Discomfort—Progesterone—uterine cancer	0.00784	0.00784	CcSEcCtD
Betahistine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00784	0.00784	CcSEcCtD
Betahistine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00772	0.00772	CcSEcCtD
Betahistine—Confusional state—Progesterone—uterine cancer	0.00767	0.00767	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—uterine cancer	0.00765	0.00765	CcSEcCtD
Betahistine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00762	0.00762	CcSEcCtD
Betahistine—Anaphylactic shock—Progesterone—uterine cancer	0.00761	0.00761	CcSEcCtD
Betahistine—Nervous system disorder—Progesterone—uterine cancer	0.00746	0.00746	CcSEcCtD
Betahistine—Tachycardia—Progesterone—uterine cancer	0.00743	0.00743	CcSEcCtD
Betahistine—Skin disorder—Progesterone—uterine cancer	0.00739	0.00739	CcSEcCtD
Betahistine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00732	0.00732	CcSEcCtD
Betahistine—Erythema multiforme—Dactinomycin—uterine cancer	0.00716	0.00716	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00714	0.00714	CcSEcCtD
Betahistine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00711	0.00711	CcSEcCtD
Betahistine—Vasodilation procedure—Epirubicin—uterine cancer	0.00696	0.00696	CcSEcCtD
Betahistine—Vasodilation—Epirubicin—uterine cancer	0.00696	0.00696	CcSEcCtD
Betahistine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00695	0.00695	CcSEcCtD
Betahistine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.0069	0.0069	CcSEcCtD
Betahistine—Dyspnoea—Progesterone—uterine cancer	0.00678	0.00678	CcSEcCtD
Betahistine—Ventricular extrasystoles—Epirubicin—uterine cancer	0.00677	0.00677	CcSEcCtD
Betahistine—Somnolence—Progesterone—uterine cancer	0.00676	0.00676	CcSEcCtD
Betahistine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00676	0.00676	CcSEcCtD
Betahistine—Bronchospasm—Etoposide—uterine cancer	0.00673	0.00673	CcSEcCtD
Betahistine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00673	0.00673	CcSEcCtD
Betahistine—Dyspepsia—Progesterone—uterine cancer	0.0067	0.0067	CcSEcCtD
Betahistine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.0067	0.0067	CcSEcCtD
Betahistine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00657	0.00657	CcSEcCtD
Betahistine—Fatigue—Progesterone—uterine cancer	0.00656	0.00656	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—uterine cancer	0.00644	0.00644	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—uterine cancer	0.00644	0.00644	CcSEcCtD
Betahistine—Feeling abnormal—Progesterone—uterine cancer	0.00627	0.00627	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.00626	0.00626	CcSEcCtD
Betahistine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00615	0.00615	CcSEcCtD
Betahistine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00613	0.00613	CcSEcCtD
Betahistine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00611	0.00611	CcSEcCtD
Betahistine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00607	0.00607	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00605	0.00605	CcSEcCtD
Betahistine—Urticaria—Progesterone—uterine cancer	0.00604	0.00604	CcSEcCtD
Betahistine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00595	0.00595	CcSEcCtD
Betahistine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00594	0.00594	CcSEcCtD
Betahistine—Malaise—Dactinomycin—uterine cancer	0.00594	0.00594	CcSEcCtD
Betahistine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00568	0.00568	CcSEcCtD
Betahistine—Hypersensitivity—Progesterone—uterine cancer	0.00561	0.00561	CcSEcCtD
Betahistine—Discomfort—Dactinomycin—uterine cancer	0.00554	0.00554	CcSEcCtD
Betahistine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00548	0.00548	CcSEcCtD
Betahistine—Asthenia—Progesterone—uterine cancer	0.00546	0.00546	CcSEcCtD
Betahistine—Pruritus—Progesterone—uterine cancer	0.00538	0.00538	CcSEcCtD
Betahistine—Diarrhoea—Progesterone—uterine cancer	0.00521	0.00521	CcSEcCtD
Betahistine—Erythema multiforme—Etoposide—uterine cancer	0.00518	0.00518	CcSEcCtD
Betahistine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00508	0.00508	CcSEcCtD
Betahistine—Dizziness—Progesterone—uterine cancer	0.00503	0.00503	CcSEcCtD
Betahistine—Immune system disorder—Etoposide—uterine cancer	0.00495	0.00495	CcSEcCtD
Betahistine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00495	0.00495	CcSEcCtD
Betahistine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00488	0.00488	CcSEcCtD
Betahistine—Vomiting—Progesterone—uterine cancer	0.00484	0.00484	CcSEcCtD
Betahistine—Rash—Progesterone—uterine cancer	0.0048	0.0048	CcSEcCtD
Betahistine—Dermatitis—Progesterone—uterine cancer	0.00479	0.00479	CcSEcCtD
Betahistine—Headache—Progesterone—uterine cancer	0.00477	0.00477	CcSEcCtD
Betahistine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00472	0.00472	CcSEcCtD
Betahistine—Fatigue—Dactinomycin—uterine cancer	0.00464	0.00464	CcSEcCtD
Betahistine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00456	0.00456	CcSEcCtD
Betahistine—Nausea—Progesterone—uterine cancer	0.00452	0.00452	CcSEcCtD
Betahistine—Feeling abnormal—Dactinomycin—uterine cancer	0.00443	0.00443	CcSEcCtD
Betahistine—Ill-defined disorder—Etoposide—uterine cancer	0.00443	0.00443	CcSEcCtD
Betahistine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00438	0.00438	CcSEcCtD
Betahistine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00435	0.00435	CcSEcCtD
Betahistine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00434	0.00434	CcSEcCtD
Betahistine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00432	0.00432	CcSEcCtD
Betahistine—Malaise—Etoposide—uterine cancer	0.0043	0.0043	CcSEcCtD
Betahistine—Convulsion—Etoposide—uterine cancer	0.00413	0.00413	CcSEcCtD
Betahistine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0041	0.0041	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—uterine cancer	0.00405	0.00405	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—uterine cancer	0.00405	0.00405	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00403	0.00403	CcSEcCtD
Betahistine—Discomfort—Etoposide—uterine cancer	0.00401	0.00401	CcSEcCtD
Betahistine—Hypersensitivity—Dactinomycin—uterine cancer	0.00396	0.00396	CcSEcCtD
Betahistine—Confusional state—Etoposide—uterine cancer	0.00392	0.00392	CcSEcCtD
Betahistine—Anaphylactic shock—Etoposide—uterine cancer	0.00389	0.00389	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—uterine cancer	0.00386	0.00386	CcSEcCtD
Betahistine—Asthenia—Dactinomycin—uterine cancer	0.00386	0.00386	CcSEcCtD
Betahistine—Asthma—Epirubicin—uterine cancer	0.00384	0.00384	CcSEcCtD
Betahistine—Tachycardia—Etoposide—uterine cancer	0.0038	0.0038	CcSEcCtD
Betahistine—Skin disorder—Etoposide—uterine cancer	0.00378	0.00378	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—uterine cancer	0.00375	0.00375	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00375	0.00375	CcSEcCtD
Betahistine—Diarrhoea—Dactinomycin—uterine cancer	0.00368	0.00368	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—uterine cancer	0.00357	0.00357	CcSEcCtD
Betahistine—Asthma—Doxorubicin—uterine cancer	0.00355	0.00355	CcSEcCtD
Betahistine—Dyspnoea—Etoposide—uterine cancer	0.00347	0.00347	CcSEcCtD
Betahistine—Somnolence—Etoposide—uterine cancer	0.00346	0.00346	CcSEcCtD
Betahistine—Vomiting—Dactinomycin—uterine cancer	0.00342	0.00342	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00339	0.00339	CcSEcCtD
Betahistine—Rash—Dactinomycin—uterine cancer	0.00339	0.00339	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00336	0.00336	CcSEcCtD
Betahistine—Fatigue—Etoposide—uterine cancer	0.00336	0.00336	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—uterine cancer	0.00321	0.00321	CcSEcCtD
Betahistine—Nausea—Dactinomycin—uterine cancer	0.00319	0.00319	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00314	0.00314	CcSEcCtD
Betahistine—Urticaria—Etoposide—uterine cancer	0.00309	0.00309	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—uterine cancer	0.0029	0.0029	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—uterine cancer	0.00287	0.00287	CcSEcCtD
Betahistine—Asthenia—Etoposide—uterine cancer	0.00279	0.00279	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—uterine cancer	0.00277	0.00277	CcSEcCtD
Betahistine—Pruritus—Etoposide—uterine cancer	0.00275	0.00275	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—uterine cancer	0.00269	0.00269	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—uterine cancer	0.00266	0.00266	CcSEcCtD
Betahistine—Flatulence—Epirubicin—uterine cancer	0.00263	0.00263	CcSEcCtD
Betahistine—Dizziness—Etoposide—uterine cancer	0.00257	0.00257	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—uterine cancer	0.00257	0.00257	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—uterine cancer	0.00248	0.00248	CcSEcCtD
Betahistine—Vomiting—Etoposide—uterine cancer	0.00247	0.00247	CcSEcCtD
Betahistine—Rash—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Betahistine—Dermatitis—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Betahistine—Headache—Etoposide—uterine cancer	0.00244	0.00244	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Betahistine—Malaise—Epirubicin—uterine cancer	0.00241	0.00241	CcSEcCtD
Betahistine—Convulsion—Epirubicin—uterine cancer	0.00232	0.00232	CcSEcCtD
Betahistine—Nausea—Etoposide—uterine cancer	0.00231	0.00231	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Discomfort—Epirubicin—uterine cancer	0.00225	0.00225	CcSEcCtD
Betahistine—Malaise—Doxorubicin—uterine cancer	0.00223	0.00223	CcSEcCtD
Betahistine—Confusional state—Epirubicin—uterine cancer	0.0022	0.0022	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—uterine cancer	0.00218	0.00218	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—uterine cancer	0.00212	0.00212	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00209	0.00209	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—uterine cancer	0.00202	0.00202	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—uterine cancer	0.00197	0.00197	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Somnolence—Epirubicin—uterine cancer	0.00194	0.00194	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00188	0.00188	CcSEcCtD
Betahistine—Fatigue—Epirubicin—uterine cancer	0.00188	0.00188	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00174	0.00174	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—uterine cancer	0.00174	0.00174	CcSEcCtD
Betahistine—Urticaria—Epirubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Betahistine—Asthenia—Epirubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Betahistine—Pruritus—Epirubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Betahistine—Dizziness—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Betahistine—Vomiting—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Betahistine—Rash—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Betahistine—Headache—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Betahistine—Nausea—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Betahistine—Rash—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Betahistine—Headache—Doxorubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Betahistine—Nausea—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
